DNAH5 and coronary artery disorder: Previous reports have linked compound heterozygosity in DNAH family members, such as DNAH9 (Fassad et al., 2018), DNAH5 (Nothe-Menchen et al., 2019), and DNAH11 (Xia et al., 2021), to the development of CHD/LD.